Ferroptosis Induction Enhances Photodynamic Therapy Efficacy for OLK
View abstract on PubMed
Summary
This summary is machine-generated.Ferroptosis induction enhances 5-aminolevulinic acid photodynamic therapy (ALA-PDT) for oral potentially malignant disorders. This combination therapy improves treatment efficacy by increasing cell death in oral leukoplakia (OLK) cells.
Area Of Science
- Oncology
- Biochemistry
- Photomedicine
Background
- Oral leukoplakia (OLK) is a significant oral potentially malignant disorder with unpredictable malignant transformation.
- Photodynamic therapy (PDT) shows promise for OLK treatment, but its efficacy is variable.
- Ferroptosis, a regulated cell death pathway, is implicated in cancer and may offer synergistic effects with antitumor therapies.
Purpose Of The Study
- To investigate whether inducing ferroptosis can improve the efficacy of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in treating OLK.
Main Methods
- Analyzed solute carrier family 7 member 11 (SLC7A11) expression in OLK patients unresponsive to ALA-PDT.
- Investigated ferroptosis induction by erastin and its combined effect with ALA-PDT on OLK cells.
- Evaluated the combined modality in a 4-nitroquinoline-1-oxide (4NQO)-induced OLK mouse model.
Main Results
- High SLC7A11 expression correlated with poor ALA-PDT response in OLK.
- ALA-PDT induced ferroptosis in OLK cells.
- Erastin-induced ferroptosis combined with ALA-PDT enhanced OLK cell death and reduced 4NQO-induced OLK lesions in mice.
Conclusions
- Ferroptosis induction, particularly with erastin, can synergistically enhance ALA-PDT efficacy for OLK.
- This combined approach disrupts the antioxidant system and increases reactive oxygen species, leading to apoptosis.
- Ferroptosis induction represents a promising strategy to improve ALA-PDT outcomes in oral potentially malignant disorders.

